Department of Medicine 3 – Rheumatology and Immunology

First Presentation of idiopathic Mast Cell Activation Syndrome (MCAS) in a Young Person: Association with Histamine and Salicylate Intolerance as well as an important Differential Diagnosis in gastroenterological Problem Patients (2019) Raithel M, Rechenauer T, Goetze T, Siebenlist G, Rueckel A, Baenkler HW, Hartmann A, et al. Conference contribution Depression as comorbidity of rheumatoid arthritis Depression als Komorbidität bei rheumatoider Arthritis (2019) Baerwald C, Manger B, Hueber A Journal article, Review article Depression as comorbidity of rheumatoid arthritis (2019) Baerwald C, Manger B, Hueber A Journal article 3Dscript: animating 3D/4D microscopy data using a natural-language-based syntax (2019) Schmid B, Tripal P, Fraaß T, Kersten C, Ruder B, Grüneboom A, Huisken J, Palmisano R Journal article, Letter Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation (2019) Heim C, Mauer J, Kuckhahn A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM Conference contribution Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death (2019) O'Donnell VB, Aldrovandi M, Murphy RC, Krönke G Journal article, Review article What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? (2019) De Vries TJ, El Bakkali I, Kamradt T, Schett G, Jansen IDC, D'Amelio P Journal article, Review article Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines (2019) Kittler J, Sommer J, Fischer A, Britting S, Karg M, Bock B, Atreya I, et al. Journal article GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE (2019) Wong L, Mescia F, Alberici F, Ball MJ, Baslund B, Brenchley P, Bruchfeld A, et al. Conference contribution EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL (2019) Stone J, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution